Also trades as: THYROCARE.NS (NSE) · $vol 4M
THYROCARE.BO BSE
Thyrocare Technologies Limited
1W: -5.7%
1M: -9.3%
3M: -3.4%
YTD: +31.5%
1Y: -61.0%
3Y: -2.9%
5Y: -56.0%
₹536.00 ($5.57)
+1.65 (+0.31%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#5
of 8
Medical - Diagnostics & Research
Technical Signal Map
2 Bullish
0 Neutral
7 Bearish
THYROCARE.BO
$85B
Thyrocare Technologies Limited
LEAN BEAR
-25
LALPATHLAB.NS
$337B
Dr. Lal PathLabs Limited
BULLISH
+75
KRSNAA.NS
$18B
Krsnaa Diagnostics Limited
BULLISH
+50
VIMTALABS.NS
$26B
Vimta Labs Limited
BEARISH
-42
SAILIFE.NS
$327B
Sai Life Sciences Limited
BEARISH
-60
VIJAYA.NS
$147B
Vijaya Diagnostic Centre Limited
BEARISH
-68
THYROCARE.NS
$85B
Thyrocare Technologies Limited
BEARISH
-84
DLCL.BO
$30M
Dr. Lalchandani Labs Ltd.
BEARISH
-91
METROPOLIS.NS
$112B
Metropolis Healthcare Limited
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| THYROCARE.BO Thyrocare Technologies Limited | $85B | 31.0 | 28.8 | 38.4 | 21.0 | 20.6 | 6 | LEAN BEAR | -61.0 |
| LALPATHLAB.NS Dr. Lal PathLabs Limited | $337B | 61.5 | 21.6 | 34.4 | 18.7 | 12.3 | 5 | BULLISH | -39.0 |
| KRSNAA.NS Krsnaa Diagnostics Limited | $18B | 18.5 | 10.9 | 8.2 | 21.7 | 7.8 | 6 | BULLISH | -29.6 |
| VIMTALABS.NS Vimta Labs Limited | $26B | 33.0 | 18.5 | 18.5 | 19.3 | 18.4 | 7 | BEARISH | -11.4 |
| SAILIFE.NS Sai Life Sciences Limited | $327B | 90.3 | 3.0 | 2.9 | 13.2 | — | 3 | BEARISH | 70.7 |
| VIJAYA.NS Vijaya Diagnostic Centre Limited | $147B | 78.1 | 19.7 | 16.7 | 21.8 | 19.6 | 7 | BEARISH | 35.2 |
| THYROCARE.NS Thyrocare Technologies Limited | $85B | 31.0 | 28.8 | 38.4 | 21.0 | 20.6 | 6 | BEARISH | -61.2 |
| DLCL.BO Dr. Lalchandani Labs Ltd. | $30M | 19.4 | 2.7 | -12.2 | 11.4 | — | 3 | BEARISH | -52.7 |
| METROPOLIS.NS Metropolis Healthcare Limited | $112B | 55.3 | 13.4 | 20.0 | 12.0 | 23.6 | 7 | BEARISH | -74.6 |
| THYROCARE.BO Thyrocare Technologies Limited | $85B | 31.0 | 28.8 | 38.4 | 21.0 | 20.6 | 6 | LEAN BEAR | -61.0 |
| LALPATHLAB.NS Dr. Lal PathLabs Limited | $337B | 61.5 | 21.6 | 34.4 | 18.7 | 12.3 | 5 | BULLISH | -39.0 |
| KRSNAA.NS Krsnaa Diagnostics Limited | $18B | 18.5 | 10.9 | 8.2 | 21.7 | 7.8 | 6 | BULLISH | -29.6 |
| VIMTALABS.NS Vimta Labs Limited | $26B | 33.0 | 18.5 | 18.5 | 19.3 | 18.4 | 7 | BEARISH | -11.4 |
| SAILIFE.NS Sai Life Sciences Limited | $327B | 90.3 | 3.0 | 2.9 | 13.2 | — | 3 | BEARISH | 70.7 |
| VIJAYA.NS Vijaya Diagnostic Centre Limited | $147B | 78.1 | 19.7 | 16.7 | 21.8 | 19.6 | 7 | BEARISH | 35.2 |
| THYROCARE.NS Thyrocare Technologies Limited | $85B | 31.0 | 28.8 | 38.4 | 21.0 | 20.6 | 6 | BEARISH | -61.2 |
| DLCL.BO Dr. Lalchandani Labs Ltd. | $30M | 19.4 | 2.7 | -12.2 | 11.4 | — | 3 | BEARISH | -52.7 |
| METROPOLIS.NS Metropolis Healthcare Limited | $112B | 55.3 | 13.4 | 20.0 | 12.0 | 23.6 | 7 | BEARISH | -74.6 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
THYROCARE.BO vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F